Endocrine disorders Flashcards

1
Q

Case
A 3740-g infant is delivered vaginally after an uncomplicated 38-
week gestation. Health-care providers have immediate difficulty
in determining whether the infant is a boy or girl.
The baby is born to a 27 year old primigravid, with no known comorbidities.
There is note of regular prenatal-check-up. Patient
was born with fair cry and fair activity. Patient has fair suck, but
not in respiratory distress
Physical examination
Asleep, comfortable, not in distress
HR 177, RR 55, sat 92% BP 60/40
Weight 3.7kg Length: 48 cm HC: 35
Anicteric sclerae, pink conjunctivae, no facial dysmorphisms
Equal chest expansion, clear breath sounds, no adventitious lung
sounds
Adynamic precordium, distinct heart sounds, no murmurs
Globular, NABS, no palpable masses
Patent anus, with small scrotal sacs that resemble enlarged labia
and no palpable testes with either a microphallus and
hypospadias or an enlarged clitoris. No vaginal opening is
apparent.
Complete digits, fair pulses, with CRT 5 secs
CBC
Hgb 155, Hct 0.51, WBC 15.0, Neuts 0.65, Lym 0.22, Plt 350
MCV 75, MCH 20, MCHC 25, RDW 19
Electrolytes
Na 131, K 5.2, Cl 88, glucose 110 mg/dL
ABG
pH 7.44, pCO2 45, pO2 94, HCO3 31, sats 99%
17OHP elevated
Karyotype: Standard XX chromosome on pair 23

A

Congenital Adrenal Hyperplasia
Autosomal recessive disorder of adrenal steroid production with
an enzymatic deficiency (usually 21-hydroxylase) causing
inadequate production of cortisol, excessive production of
androgenic intermediary metabolites, and virilization

Microphallus
*Phallic size is the most important physical exam as it can determine sex (Pediatr Rev)
-Will not present with toxic looking infant, but cannot be totally ruled out.

Virilization
*Ambiguous genitalia
-Will not present
with toxic looking infant, but cannot be totally ruled out.

Neonatal sepsis
*Due to hypotension and poor perfusion
-Ambiguous genitalia is not
present. But concomitant illness has to be ruled out

Inborn error of
metabolism
*Presence of hypotonia, with toxic looking infant
-Ambiguous genitalia is not
present. But concomitant illness has to be ruled out

True hermaphroditism
(Sex chromosome DSD, ovotestis,
mixed gonadal dysgenesis)
-Ambiguous
genitalia Will not present
with toxic looking infant,
but cannot be totally ruled out.

CBC+/- blood cultures to rule out sepsis
Electrolytes and fingerstick glucose
ABG check for acidosis for IEM
Newborn screen, confirmatory 17OHP
Karyotype as emergency
Abdominal ultrasound to check for gonads
Management
Fluid resuscitation – fluid maintenance – replace salt loss
Maintain normoglycemia
Hydrocortisone supplementation (think fludrocortisone
supplementation)
General Pediatrics
Chronic therapy with oral hydrocortisone and fludrocortisone
Address dose adjustment during acute stress
Growth monitoring, immunization, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CH 576-580: ADRENAL DISORDERS
Adrenal gland
1) Cortex – steroid synthesis
a. Glomerulosa – aldosterone (Na retention, K secretion)
b. Fasciculata – cortisol
c. Reticularis – sex steroids (androgen, DHEA)

2) Inner medulla – catecholamines (dopamine, E, NE)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is CAH?

A

CONGENITAL ADRENAL HYPERPLASIA (CAH)
Etiopatho
- Autosomal recessive disorder of cortisol synthesis
leading to inc secretion of ACTH (corticotropin) causing
adrenal hyperplasia and overproduction of metabolites
- Deficiency of 21-hydroxylase (90%)
o Causes excess substrates shunted towards
synthesis of sex hormones
o Adrenal insufficiency + ambiguous genitalia
(F infants)
o Lack of 21hydroxylase à no cortisol and
aldosterone à shunting of substrates
towards testosterone/estradiol production
o Common in PH (1:10,000)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical manifestations of CAH?

A

CM
1. Progressive wt loss, anorexia, vomiting, dehydration
2. Weakness, hypotension
3. May appear at 2wks of age
4. Shock, arrythmia, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the types of CAH?

A

Salt-losing, classic form

Simple Virilizing, classic form

Non-classic form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the salt-losing, classic form?

A

-70% of patients with classic 21-hydoxylase deficiency
-wt loss, anorexia, nausea, vomiting, weakness, salt craving
-hypoglucemia, hyponatremia, hyperkalemia, metabolic acidosis
-symptoms appear at 10-14 days of age
-signs of virilization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is simple virilizing, classic form?

A

-30% of patients with classic 21-hydroxylase deficiency
Signs of virilization:
*female infants: ambiguous genitalia/masculinized external genitalia (clitoral enlargement, labial fusion, urogenital sinus)
*Male infants: appear normal at birth. postnatal signs of androgen excess include rapid somatic growth, accelerated skeletal maturation, stunting, pubic and axillary hair, acne, deep voice, enlarged penis, scrotum and prostate but prepubertal testes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the nonclassic form?

A

-attenuated, late onset form of adrenal hyperplasia
-may be asymptomatic, or may have precocious adrenarche, hirsutism, acne, menstrual irregularity, infertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is CAH diagnosed?

A

Dx
1. Inc serum 17-OHP – most reliable to establish 21-
hydroxylase deficiency
2. Low serum cortisol
3. Elev ACTH, renin
4. Low aldosterone (inappropriate for renin level)
5. Hypoglycemia, hyponatremia, hyperkalemia
6. NBS and confirmatory tests (17-OHP, serum Na, K, RBS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

APPROACH to infant with GENITAL AMBIGUITY

A

APPROACH to infant with GENITAL AMBIGUITY
- PE – note where urethral opening lies and check fusion
of anterior portion of labioscrotal folds
- If vaginal opening open but clitoris enlarged – late exposure to androgens
- Fully formed scrotum, normal and small penis (microphallus) – normal exposure to androgen during
9-13 wks AOG
- GOAL: identify life threatening disorders (CAH)
- 46XY (Swyer syndrome) – small phallus that does not
increase in size after androgen therapy à usually
raised as female, some revert to male gender
1. First step: determine whether
- virilization of female
- underdevt of male
2. UTZ to check for organs
3. Karyotype determination
4. Usually CAH in females – determine level of 17OH and
androstenedione; Harder in males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is CAH managed?

A

Mgt
1. Correct shock and dehydration
- 1st hr: D5%NSS 20 ml/kg
- Maintenance IVF: correct e’ abN
2. Replace deficient hormones
a. CS – inhibit excessive production of androgens and prevent progressive virilization
o Hydrocortisone initially 100 mg/m2 IV then
100 mg/m2 in the next 25h, then 15-
20mg/m2/d in 3 divided doses
o Double/triple doses during periods of stress
(surgery, infection)
o Continued indefinitely in classic 21- hydroxylase deficiency
o Monitor growth and hormonal levels
o At or near completion of linear growth (puberty): Prednisone/Prednisolone,
Dexamethasone
b. Fludrocortisone 100 mcg/tab 0.05-0.10 mg/m2– mineralocorticoid replacement
3. NaCl supplementation 1g/tab OD – for salt-losing ds
- 1g NaCl = 17 mEq Na
4. Surgery – for ambiguous genitalia
Surgical restoration:
- gonads and internal organs discordant to gender
decide to be removed
- dysgenetic gonads with Y material remove to prevent
gonadoblastomas or dysgerminoma
- reconstructive surgery usually at 2 years old
5. Psychological support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Addison disease?

A

Patho
- Acquired primary adrenal insufficiency
- Early: isolated cortisol deficiency
- Late: all adrenocortical fxn lost

Etiology
- MC: autoimmune destruction of adrenal glands,
usually sparing the medulla
- Infection (MC: meningococcemia (Waterhouse- Friderichsen syndrome)
- Drugs (ketoconazole, mitotane, etomidate)
- Hemorrhage from child abuse/anticoagulant use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the clinical manifestations of Addison disease?

A

CM
1. Muscular weakness, malaise, anorexia, nausea,
vomiting, weight loss, orthostatic hypotension, salt
craving
2. Inc skin pigmentation (skin creases, mucosa, scars)
3. Acute decompensation (adrenal crisis) during minor
infectious illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diagnostics of Addison

A

Blood:
*low serum Na, increased K
*hypoglycemia, ketosis, acidosis
*high ACTH with low or inappropriately normal cortisol and aldosterone
*most definitive test: measurement of serum levels of cortisol before and after administration of ACTH (cortisol is low and does not increase normally after ACTH administration)

urine electrolytes:
*elevated urinary excretion of Na and Cl-
*low urinary excretion of K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of Addison

A

For acute Adrenal Insufficiency:
*D5 0.9 NSS IV: to correct hypoglycemia, hypovolemia, hyponatremia
*Hydrocortisone succinate:
-IV bolus then divided doses every 6 hours for 1st 24 hours (50mg/m2 IV bolus then 25-100 mg/m2/day as IV infusion or in divided doses every 6 hours), or
*As much as 10mg for infants, 25mg for toddlers, 50mg for older children and 100mg for adolescents administered as bolus, and similar amount in divided doses every 6 hours for the first 24 hours

Chronic replacement therapy:
*Hydrocortisone 10mg/m2/day in 3 divided doses, or equivalent doses if prednisone twice daily
*Fludrocortisone if with aldosterone indufficiency
*Monitor ACTH levels
*Prevention of adrenal crisis:
Increase in hydrocortisone dose 2-3 fold during stress (infection/surgery(
*Advise parents to visit ER if with persistent vomiting and unable to tolerate oral hydrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the clinical manifestations of pheochromocytoma?

A

CM
1. HTN – sustained > paroxysmal
2. Headache, palpitations, abdominal pain, dizziness,
pallor, vomiting, sweating, convulsions
3. Asx’c in between HTN
4. Polyuria, polydipsia, growth failure
5. Severe: precordial pain radiating into arms, pulmonary
edema, cardiomegaly, hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the diagnostics for pheochromocytoma?

A

Catecholamine levels
-elevated blood or urinary levels of catecholamines (eg. dopamine, norepinephrine, epinephrine) and metabolites (normetanephrine, metanephrine)
-predominant cathecholamine excreted in urine among children is norepinephrine
-best sensitivity and specificity: measurement of plasma metanephrine
-urinary excretion VMA is increased but no longer routinely used due to false-positive results from consumption of vanilla-containing food

Imaging
-CT, MRI - to localize tumor
-85% of tumors are found in adrenal glands, 95% are within the abdomen and pelvis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the management?

A

Mgt
1. Surgical removal of tumor
2. Pre-operative a & b-adrenergic blockade and fluid
loading
3. Transabdominal exploration of all usual sites because
tumors are often multiple

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Differentials?

A

Cushing syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Disorders of gonads and puberty

A

BOYS
-Complete sexual maturity is
usually achieved by 17-18yo
-Sequence of pubertal
events: testicular
enlargement, adrenarche,
continued testicular and
penile enlargement, peak
height velocity with peak
weight velocity
-gynecomastia (60%) at SMR
2-4
-ejaculation at SMR3
-voice change at SMR 3-4
-fertility established at SMR 4

GIRLS
-sequence of pubertal events:
thelarche, adrenarche, peak
height velocity, continued
breast and hair development,
menarche, completion of
puberty
-ave duration of completion
of puberty is 4 yrs
-menarche (90%) during SMR
4
-Filipino girls ave age of
menarche 13.3 yrs and cycles
may be anovulatory for 2 yrs
after menarche
-full fertility usually achieved
within 2 yrs of menarche (ave
age 14-15yo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

give the SMR stages in females

A

PUBIC HAIR
1-preadolescent
2-sparse, lightly pigmented, straight, medial border of labia
3-darker, beginning to curl, increased amount
4-coarse, curly, abundant, but less than in adult
5-adult feminine triangle, spread to medial surface of thighs

BREASTS
1-preadolescent
2-breast and papilla elevated as small mound; diameter of areola increased
3-breast and areola enlarged, no contour separation
4-areola and papilla form secondary mound
5-mature, nipple projects, areola part of general breast contour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Give the SMR stages in males

A

PUBIC HAIR
1- none
2-scanty, long, slightly pigmented
3-darker, starting to curl, small amount
4-resembles adult type, but less quantity; coarse, curly
5-adult distribution, spread to medial surface of thighs

PENIS
1-preadolescent
2-minimal change/enlargement
3-lengthens
4-larger, glans and breadth increase in size
5-adult size

TESTES
1-preadolescent
2-enlarged scrotum, pink, texture altered
3-larger
4-larger, scrotum dark
5-adult size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

DISORDERS OF GONADS

A

Patho
-internal and ext genitalia formed at 6-13 wks AOG
-fetal gonad and external genitalia – bipotential (can develop into
male and female phenotype)
-presence of SRY –> differentiates into a testes –> Leydig cells
secrete testosterone –> converted to DHT –> causes enlargement,
rotation and fusion of the labioscrotal folds into scrotum –> forms penis
-female phenotype develops unless specific male influences alter
development
-total absence of androgens –> female

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Genetic causes of hypertrophic hypogonadism

A

Noonan syndrome
Klinefelter syndrome
Turner syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is Noonan syndrome?

A

NOONAN SYNDROME
Affectation: males and females
Karyotype: Normal

Clinical:
short stature, webbing of the neck, low hairline, pectus carinatum/excavatum, right-sided CHD (mainly valvular, pulmonic stenosis), cardiomypathy, cubitus valgus, hypertelorism, downward slanted palpebral fissures, ptosis, micrognathia
Subnormal IQ, high frequency sensorineural hearing loss
cryptochordism, small testes, delayed puberty

Management: Human GH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is Klinefelter Syndrome?

A

KLINEFELTER

affects males
Karyotype: 47 XXY
48 XXXY, 48 XXYY, 49 XXXYY

*diagnosis rarely made before puberty due to paucity of signs and symptoms in childhood
*behavioral or psychiatric disorders *anxious, immature, or excessively shy), learning disabilities, verbal cognitive defects, deficits in executive function
*tall, slim, long legs disproportionate to the arms
*small testes and phallus, cryptochordism, low testosterone, delayed puberty, gynecomastia, sparse facial hair, azoospermia, infertility
*increased incidence of metabolic syndrome, breast cancer, leukemia, lymphoma

Management: replacement therapy with testosterone preparation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is Turner Syndrome?

A

TURNER SYNDROME
affects females
Karyotype: 45, X

  • recognizable at birth: edema of dorsa of the hands and feet, loose skin folds at the nape, low birth weight, decreased length

*short stature (cardinal finding), webbed neck, low posterior hairline, small mandible, high arched palate, prominent ears, epicanthal folds, broad chest with illusion of widely spaced nipples, cubitus valgus, hyperconvex fingernails

*cardiac defects (mainly bicuspid aortic valve), renal malformations, IBD

*nearly all oocytes are gone by 2 years (ovaries described as “streaks”

*breast development fails to occur but adrenarche normally present

Management: Human GH
Estrogen replacement therapy

29
Q

Normal Puberty

A

Girls:
o Thelarche (breast bud) –> pubarche (6-12
mos later) –> menarche (2-2.5 yrs from
thelarche)
o Peak height velocity: breast stage 2-3

Boys:
o Growth of testes (>4ml) and thinning of
scrotum –> growth of penis and
pigmentation of scrotum –> pubarche
o Peak height velocity: genital stages 4-5

30
Q

What is precocious puberty?

A

Etiopatho
- onset of secondary sexual characteristics (breast devt
or testicular devt) before:
o 8 yo in girls
o 9 yo in boys
- classification based on primary source of hormonal
production

31
Q

Pathophysiology of precocious puberty

A

Hypothalamus secretes GnRH (gonadotropin releasing hormone) –> pituitary releases LH and FSH –> gonads secrete sex steroids
(testosterone from testes, estradiol and progesterone from
ovaries)
Females - FSH – ovarian production of estrogen, in puberty causes
formation and support of corpus luteum
Males – LH – production of testosterone from Leydig cells, later
FSH stimulates development and support of seminiferous tubules
Sex steroids and inhibin (produced by gonads) – both suppress the
secretion of gonadotropins
GnRH released in episodic pulses vary during development and
menstrual period
- onset of puberty, increased at night than during the
day
- Adrenarche then Gonadarche

32
Q

What are the differences between Central vs Peripheral precocious puberty?

A

CENTRAL PRECOCIOUS PUBERTY
Etiology: Idiopathic (most frequent cause among females), brain lesions (hypothalamic hemartoma, tumor, hydrocephalus, trauma, myelomeningocele, abscess, radiation), untreated hypothyroidism

Labs: elevated LH and FSH
serial blood samples during sleep reveals pulsatile LH secretion
Pubertal levels of testosterone or estradiol
GnRH or GnRH agonist (leuprolide) stimulation test leads to “pubertal” LH response or pubertal levels of estradiol

Imaging: advanced osseous maturation
Pelvic UTZ in girls; progressive enlargement of ovaries and uterus
MRI: physiologic enlargement of pituitary gland as seen in normal puberty

Tx: GnRH agonist

PERIPHERAL PRECOCIOUS PUBERTY
Etiology: ovarian tumors, Leydig cell tumor, adrenal tumo, CAH, teratoma, Mc-Cune-Albright syndrome

Labs: Supressed LH, FSH
Elevated estradiol or testosterone
No response to GnRH or leuprolide stimulation test

Imaging: Advanced osseous maturation
polyostotic fibrous dysplasia in McCune-Albright syndrome

Tx: Aromatase inhibitors: letrozole, testolactone
Anti-estrogen: Tamoxifen
Anti-androgens: spinorolactone, flutamide, bicalutamide
Inhibitor of testosterone synthesis: ketoconazole

33
Q

Incomplete (partial) precocious puberty

A

Incomplete (partial) precocious puberty
- isolated manifestations of puberty without devt of
other pubertal signs

34
Q

What is premature thelarche?

A

-transient isolated breast -development without other pubertal changes
-most often occurs in the first 2 yrs of life
-infrequently may progress to precocious puberty

35
Q

What is premature pubarche or adrenarche?

A

-early apperance of pubic hair
-early increase in adrenal androgen production
-increased prepubertal growth velocity but decreased pubertal growth, so adult height is not affected
-may herald disorders of androgen synthesis

36
Q

What is premature menarche? (rare)

A

-majority will have only 1-3 episodes of bleeding
-puberty occurs usual time

37
Q

What is delayed puberty?

A

Delayed puberty
- No physical changes of puberty by age:
o 13 yo in girls
o 14 yo in boys
- No menarche by 16 yo in girls who developed
secondary sexual characteristics
- Dx: LH/FSH, Bone aging, TFT, Karyotyping
- Mgt: hormonal replacement

38
Q

CH 571-573: DISORDERS OF PARATHYROID

A

Parathyroid hormone (PTH) – stimulates activity of 1alphahydroxylase
in kidneys, increases serum Ca by enhancing bone
resorption and facilitates phosphorous excretion
Vitamin D deficiency – low Ca, normal Ph

39
Q

Etiology of hypoparathyroidism

A

Etiology
- Neonatal, congenital, postsurgical/radiation
destruction, hypo/hyperMg, VitD deficiency, Ca
deficiency, drugs (furosemide, aminoglycosides,
calcitonin, bisphosphonates, anticonvulsants,
ketoconazole, antineoplastic agents), sepsis, acute
pancreatitis
- Destruction/aplasia/impaired synthesis of parathyroid
gland à dec PTH à hypoCa, hyperPh

40
Q

What are the clinical manifestations of hypoparathyroidism?

A

CM
1. Muscular pain and cramps (early), numbness, stiffness,
tingling of hands and feet
of hands and feet

  1. (+)Chvostek or Trousseau sign or laryngeal and
    carpopedal spasms
  2. Abdominal pain –> tonic rigidity, head retraction,
    cyanosis –> Sz w/ or without LOC
41
Q

What are the diagnostics for hypoparathyrodism?

A

Dx
1. Serum PTH – dec
2. Serum Ca, Ph, 1,25(OH)2D, Mg - dec Ca, elev Ph
3. ECG – prolonged QT

42
Q

What is the management of hypoparathyroidism?

A

Mgt
1. Calcium gluconate 10% IV 5-10mL at 0.5-1 ml/min with
HR monitoring
2. Calcitriol 0.25ug/d
3. Calcium gluconate or calcium glubionate 800mg daily

43
Q

What is PSEUDOHYPOPARATHRYOIDISM?

A
  1. Pseudohypoparathyroidism (PHP) or Albright
    Osteodystrophy – elev PTH but dec Ca
    - Due to PTH receptor defect
    - Short child, stocky build, round face with dimpling of
    hands
    - Tetany – usual presenting sign
  2. Pseudohypoparathyroidism – have the usual anatomic
    stigmata of PHP
    - Slightly elevated PTH but normal Ca and Ph
    - Hypocalcemia occurs with increasing age
44
Q

What is hyperparathyroidism?

A

HYPERPARATHYROIDISM
- Usually manifest after 10yo
- MEN type I – hyperplasia of pancreas + ant pituitary +
parathyroid gland

45
Q

Pathophysiology of hyperparathyroidism?

A

Patho
- May be from adenoma or hyperplasia of parathyroid
gland (primary) or a compensatory increase from a
hypocalcemic state (secondary) –> inc PTH –> hyperCa,
hypoPh

46
Q

What are the clinical manifestations of hyperparathyroidism?

A

CM
1. Muscle weakness, fatigue, headache
2. anorexia, abdominal pain, nausea, vomiting,
constipation
3. polydipsia, polyuria, weight loss, fever
4. renal calculi (chronic)
5. osseous changes – pain in back/ext, gait disturbance,
genu valgum, fractures, tumors
6. parathyroid crisis – serum Ca >15mg/dL + progressive
oliguria, azotemia, stupor, coma
7. cognitive impairment, sz, blindness
8. depression, confusion, dementia, stupor, psychosis

47
Q

What are the diagnostics for hyperparathyroidism?

A

Dx
1. Elev PTH
2. elev Ca (>12 mg/dl), dec Ph (<3mg/dl), dec Mg
3. XR – resorption of subperiosteal bone: most consistent
and characteristic finding
- Best seen along the margins of the phalanges of the
hands

48
Q

Management of hyperparathyroidism?

A

Mgt
1. Surgical exploration – indicated in all instances:
excision of adenoma/ total parathyroidectomy
2. Bisphosphonates, calcimimetics
3. High Ca and Ph diet

49
Q

What is hyperthyroidism?

A

CH 568: HYPERTHYROIDISM
- Excessive secretion of thyroid hormone
- Graves disease: MC cause in childhood (95%)

50
Q

What is Graves disease?

A

GRAVES DISEASE
Etiopatho
- Autoimmune disorder of thyrotropic receptorstimulating
binding Ab (TRSAb) production
- F>M (5:1)
- MC of pedia hyperthyroidism
- Peak 11-15yo
- Most have FHx of autoimmune thyroid ds

51
Q

What are the clinical manifestations of Graves disease?

A

CM
1. Finger tremors
2. Nervousness, headaches, difficulties with sleep, poor
concentration
3. Voracious appetite with weight loss or no increase in
weight
4. Flushed skin with excessive sweating, heat intolerance
5. Earliest sign: emotional disturbance with motor
hyperactivity
6. Diffuse enlarged thyroid (goiter)
7. Exophthalmos – due to Ab vs Ag shared by the thyroid
and eye ms
8. Retraction of upper eyelid (Dalrymple sign), lagging of
upper eyelid on downward gaze, infrequent blinking,
impairment of convergence
9. Tachycardia, weight loss, palpitations, dyspnea, HTN,
widened pulse pressure

52
Q

What are the diagnostics for Graves disease?

A

Dx
1. TFT – inc T4 and T3, low TSH
2. Thyroid Ab – TRSAb confirms dx
3. Thyroid UTZ and scintigraphy – diffusely enlarged
thyroid gland
- Often homogenous with normal or hypoechogenicity
- RAI uptake measured in scintigraphy if hx, PE, & lab
tests cannot establish dx
- Inc uptake of 99mTc

53
Q

Management of Graves?

A

Antithyroid drugs-1st line of tx for pregnant and children

PTU
MOA: inhibit iodine organification and coupling in the thyroid; also inhibits peripheral conversion of T4 to T3

heavily protein bound, less able to cross placenta and pass into breastmilk; preferred drug during pregnancy and lactation

administration: administered 3x daily

AE: transient granulocytopenia
transient urticarial rashes
agranulocytosis
hepatitis, lupus-like polyarthritis syndrome, glomerulopnephritis

METHIMAZOLE/CARBIMAZOLE
blocks the organification of iodide needed to synthesize the thyroid hormone

more potent than PTU
Carbimazole: is the prodrug of methimazole
consensus is to use methimazole for children
clinical response is evident within 2-4 months

Admin: initial dose 0.5-1 mg/kg/day given OD or BID

AE: transient granulocytopenia
transient urticarial rashes
agranulocytosis
hepatitis, lupus-like polyarthritis syndrome, glomerulopnephritis

54
Q

Preferred antithyroid drugs for pregnant/nursing mothers due to lesser ability to cross placenta and pass into breastmilk

A

PTU

55
Q

Other management for Graves

A
  1. Radioactive iodine ablation/ thyroidectomy
  • Indications:
    o Inadequate cooperation for medical mgt
    o Medical mgt failed to result in permanent
    remission
    o Severe SE preclude use of antithyroid drugs
  • Px should be in euthyroid state prior to radiofrequency
    ablation or surgery
  • Thyroidectomy – if with coexisting suspicious nodule
  • Consequence = permanent hypothyroidism
  • Complications:
    o Radiofreq ablation: worsen
    ophthalmopathy
    o Thyroidectomy: laryngeal nerve damage,
    hyperparathyroidism
56
Q

What is thyroid storm?

A

THYROID STORM
- Acute life-threatening surge of thyroid hormone in the
blood usually precipitated by surgery, trauma,
infection, or radioactive iodine tx
- Fever, tachycardia, high output CF, GI dysfunction
(vomiting, diarrhea, jaundice), neuro changes
(confusion, agitation, obtundation)
- Rapid progression to delirium, coma, death

57
Q

What is the management of thyroid storm?

A

Mgt
1. Inhibition of TH formation and secretion – PTU, saturated solution of potassium iodide (only after PTU to avoid potential inc in TH synthesis)

  1. Sympathetic blockade – propranolol: treat exaggerated
    adrenergic sx. Inhibits peripheral conversion of T4 to T3
  2. Tx for relative glucocorticoid insufficiency – prednisone
58
Q

What is diabetes insipidus?

A

CH 559: DIABETES INSIPIDUS
Etiopatho
- From vasopressin deficiency (central DI) or vasopressin
receptor insensitivity (nephrogenic DI)
- Vasopressin – principal regulator of tonicity
o Secreted in the posterior pituitary gland
o Antidiuretic and vascular pressor activity

59
Q

What are the clinical manifestations of DI?

A

CM
1. Polyuria and polydipsia (>2L/m2/d) – cardinal fx
2. dehydration

60
Q

Diagnostics for DI?

A

Dx
1. Serum osmolality
2. BUN, crea, Na, K, Ca
3. Glu
4. Urine osmolality, specific gravity, urine glu
DI = serum osmolality > 300 mOsm/kg and
Urine osm < 300 mOsm/kg

Serum Osm 270-300 –> perform water deprivation test to
establish dx and differentiate central from nephrogenic DI
Hyponatremia – usual reason for referral
- Then check UO, is px polyuria (DI) /oliguria (SIADH)?
- For DI: then check USg –> If <1.010 = DI

61
Q

differentials

A

SIADH
Cerebral salt wasting
Central DI
Nephrogenic DI

62
Q

What are the finding and management in SIADH?

A

Serum Na: low
Serum osmolality: low

Urine Na: High
Urine output: normal or low

Intravascular volume status: high

Vasopressin level: high

Management: limit oral fluid intake

63
Q

What are the findings and management in cerebral salt wasting?

A

Serum Na: low
Serum osmolality: low

Urine Na: VERY HIGH
Urine output: HIGH

Intravascular volume status: low

Vasopressin level: low

Management: NaCl and H2O replacement

64
Q

What are the findings and management in Central DI?

A

Serum Na: HIGH
Serum osmolality: HIGH

Urine Na: low
Urine output: HIGH

Intravascular volume status: low

Vasopressin level: low

Management: fluid therapy; vasopressin

65
Q

What are the findings and management in Nephrogenic DI?

A

Serum Na: HIGH
Serum osmolality: HIGH

Urine Na: low
Urine output: High

Intravascular volume status: low

Vasopressin level: high

Management: Thiazides +- indomethacin or amiloride

66
Q

management of Central/Neurogenic DI?

A

etiology:
congenital
trauma(deceleration injury)
Tumors (craniopharyngioma, lymphoma, leukemia(
Autoimmune
Infection (meningitis, TB)
Drugs: Ethanol, phenytoin, opiate antagonists, alpha-adrenergic agents)
Vascular (bleed or infarction)
Idiopathic in 10%

Management:
Fluid therapy’
long-acting vasopressin analog DDAVP
acute onset after neurosurgery: vasopressin with a total fluid intake limited to 1L/m2/ day during antidiuresis

67
Q

What is Nephrogenic DI?

A

etiology:
congenital
hypercalcemia,hypokalemia
renal disease (polycystic kidney disease, Chronic renal failure, ATN, obstructive uropathy)
Drugs (lithium, ciplatin, methoxyflurane, democlocycline)
Infiltrating lesions
vascular (sickle cell anemia)
Solute diuresis (glucose, mannitol, Na, radiocontrast dyes

Management:
treat underlying disorder
thiazides(decrease overall urine output by enhancing Na excretion at the expense of water and by causing decrease in GFR
Indomethacin and amiloride +/- thiazides to further reduce polyruria
Ensure intake of adequate calories for growth & to avoid severe dehydration

68
Q
A